Cancer immunotherapies often lack efficacy because the microenvironment of solid tumours is hostile, with nutrient limitation, lactate-mediated acidification and hypoxia converging to suppress the infiltration and antitumoural activity of CD8+ T cells2,10–13. The gene discussed is CD8A; the disease is cancer.